Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

The 2024 Innovator Award will cover four years of Ramanujam and her team’s work to reduce the burdens of cancer treatments on ...

“We look forward to presenting updated data from our ongoing Phase 2 clinical study of palazestrant in combination with ribociclib in frontline metastatic breast cancer patients at SABCS in December.

Komen's total investment of more than $1.1 billion in research and $2.3 billion in real-time support for patients and those living with metastatic breast cancer. Throughout the weekend, San Diego ...

A scientist who was diagnosed with stage 3 cancer treated herself using lab-grown viruses, a method researchers say is 'not ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

“Onco360 is grateful for the opportunity to partner with the team at Genentech and become a specialty pharmacy provider for Itovebi ™ ,” said Benito Fernandez. “We are proud to add another treatment ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes.

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...